Compared with the patients who received no neoadjuvant treatment, the patients who underwent neoadjuvant treatment without CPR were older (p = 0.026) and had a lower model for end-stage liver disease (MELD) score (p < 0.001), larger tumors (p < 0.001), a greater total tumor volume (p < 0.001), a higher AFP model (p = 0.009), a higher Metroticket 2.0 model (p = 0.003), and a nonsignificantly higher AFP (p = 0.071). The gene discussed is AFP; the disease is neoplasm.